A similar pattern of TET2 dysregulation has been observed in hematological malignancies, particularly in AML, a setting in which TET2 mutations are frequent38 and contribute to leukemia stem cell (LSC) generation, expansion, and maintenance. The gene discussed is TET2; the disease is leukemia.